| tyyppi : |
Lehti |
| Internet-yhteys : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386 |
|
| tutkimus Joukkueet : |
Montreal - Faculté de pharmacie, Université de Montréal |
| Tekijät : |
Friciu M, Zaraa S, Leclair G. |
| Otsikko : |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions |
| Numero : |
Can J Hosp Pharm ; 69, 4: 327-329. 2016 |
|
| Todisteiden määrä : |
|
| fyysinen vakaus : |
|
| kemiallinen stabiilisuus : |
|
| Muut menetelmät : |
|
| commentairesvaleur : |
|
Luettelo yhdisteistä
 Amlodipine besylate
|
 |
 |
 |
 |
30 mg
Norvasc® |
|
23-27°C |
 |
| 60 |
 |
|
|
|
|
 |
30 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 60 |
|
|
|
|
|
|
30 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
30 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
 |
|
1 mg
Norvasc® |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
| 45 |
|
|
|
|
|
|
1 mg
Norvasc® |
|
3-7°C |
|
| 90 |
|
|
|
|
|
|
1 mg
® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
| 90 |
|
|
|
|
|
